APA (7th ed.) Citation

Geng, X., Liu, Y., Diersch, S., Kotzsch, M., Grill, S., Weichert, W., . . . Dorn, J. (2017). Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer. PloS one, 12(11), e0186847. https://doi.org/10.1371/journal.pone.0186847

Chicago Style (17th ed.) Citation

Geng, Xiaocong, Yueyang Liu, Sandra Diersch, Matthias Kotzsch, Sabine Grill, Wilko Weichert, Marion Kiechle, Viktor Magdolen, and Julia Dorn. "Clinical Relevance of Kallikrein-related Peptidase 9, 10, 11, and 15 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." PloS One 12, no. 11 (2017): e0186847. https://doi.org/10.1371/journal.pone.0186847.

MLA (9th ed.) Citation

Geng, Xiaocong, et al. "Clinical Relevance of Kallikrein-related Peptidase 9, 10, 11, and 15 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." PloS One, vol. 12, no. 11, 2017, p. e0186847, https://doi.org/10.1371/journal.pone.0186847.